INTRODUCTION
============

*Salmonella enterica* is recognized as the most frequent cause of foodborne disease in the world ([@B13]; [@B10]). Foodborne outbreaks caused by this pathogen are mainly associated with the consumption of chicken meat, eggs, and egg products ([@B14]; [@B26]). A number of studies have shown that previous exposure of *S. enterica* to a single stressful condition could result in homologous or heterologous tolerance and increasing subsequent resistance to the same or different environment stresses ([@B2]; [@B7]; [@B22]). Salts and acids are traditionally used to process and preserve food, and these compounds impose stress conditions on bacterial cells to limit their growth and survival. However, it has been reported that the exposure of *S. enterica* to subinhibitory conditions imposed by these classical antimicrobial compounds can undergo genetic and physiologic changes. These changes allow the cells to become more resistant in subsequent exposures to the antimicrobial compounds, due to the development of a tolerance response ([@B3]; [@B25]; [@B27]).

One of the concerns related to the increase of antimicrobial resistance in *Salmonella* is the reduction of the clinical efficacy of antibiotics, particularly the quinolones, resulting in treatment failure. Ciprofloxacin (CIP) is a 2^nd^ generation quinolone, is one of the first-choice agents used to treat salmonellosis. However, a significant rise in the number of *Salmonella* strains with reduced susceptibility to this antibiotic has been observed in humans and food involved outbreaks ([@B8]; [@B20]; [@B4]).

*Origanum vulgare* L. essential oil (OVEO) has been cited as a potential compound to control the growth and survival of *S. enterica* in food ([@B10]; [@B17]), due to strong anti-*Salmonella* activity, as shown in laboratory media and in food-mimicking models ([@B1]; [@B16]). However, there is a lack of information regarding the effects of exposure to OVEO on the development of tolerance in multidrug-resistant *S. enterica* to antimicrobials traditionally used to prevent the infection of this bacterium in food industry or for therapeutic treatment of salmonellosis. Knowledge about the magnitude of tolerance induction in foodborne pathogens, particularly in *S. enterica*, which possesses a large diversity of resistance mechanisms ([@B25]), must be a requisite for the development of anti-bacterial compounds, such as OVEO, that are considered for application in food preservation systems.

Considering these aspects, the aim of this study was to assess the effects of the exposure of multidrug-resistant epidemic *S. enterica* strains to subinhibitory concentration of OVEO for different time intervals on the development of bacterial tolerance to salts and organic acids used by the food industry, as well to CIP, a therapeutic drug of human salmonellosis.

MATERIALS AND METHODS {#s1}
=====================

ESSENTIAL OIL AND ANTIMICROBIALS AGENTS
---------------------------------------

The antimicrobial agents used in this study were OVEO (Laszlo Aromaterapia Ltda., Minas Gerais, Brazil), CIP (Oxoid, UK), sodium chloride (NaCl P.A.), potassium chloride (KCl), glacial acetic acid (AA), and lactic acid (LA, 85%; Vetec Ltda., Rio de Janeiro, Brazil). According to the technical report presented by the supplier, carvacrol is the most prevalent compound in the OVEO assayed in this study (66.1 g/100 mL), followed for *p*-cymene (12.4 g/100 g) and γ-terpinene (8.3 g/100 g). OVEO solutions (40--0.3 μL mL^-1^) were prepared in sterile brain heart infusion (BHI) broth (Himedia, India) and Tween 80 (1%; Sigma--Aldrich, USA) was added as an emulsifier. Preliminary test were conducted to ensure that the antibacterial activity was because of the OVEO and not Tween 80. The results demonstrated that Tween 80 at the given concentration did not inhibit the growth of the assayed bacterial strains cultivated in BHI broth. Solutions of NaCl (600--50 mg mL^-1^), KCl (600--50 mg mL^-1^), AA (160--1.25 μL mL^-1^), and LA (160--1.25 μL mL^-1^) were prepared in sterile BHI broth.

TEST STRAIN
-----------

The test microorganisms used in this study included *S*. Enteritidis 209, isolated from feces of outbreak patient, *S.* Typhimurium 149, isolated from food involved in outbreak and *S.* Corvallis 297 isolated from poultry (chicken hens). The strains were resistant to aminoglycosides (gentamicin and streptomycin); β-lactams (ampicillin and cefotaxime); quinolones (norfloxacin and nalidixic acid), and sulphametoxazole-trimethoprim. The strains were characterized according to their quinolone resistance mechanism(s) as described in **Table [1](#T1){ref-type="table"}** ([@B24]; [@B8],[@B9]). Stock cultures were kept at 4 C before use. Each strain was grown in BHI broth at 37°C for 18 h (late exponential growth phase), harvested by centrifugation (4500 *g,* 15 min, 4°C), washed twice in sterile saline solution (NaCl, 0.85%), and resuspended in sterile saline solution to obtain standard cell suspensions at which the OD reading at 660 nm (OD~660~) was 0.1 (c.a. 10^7^ CFU mL^-1^; [@B19]).

###### 

Resistance mechanisms and the minimum inhibitory concentration (MIC) of essential oil from *Origanum vulgare* L. and ciprofloxacin (CIP) against multidrug-resistant *Salmonella enterica* strains isolated from human outbreaks or from poultry origin.

  Test strains           Resistance mechanism\*            MIC\*\* of OVEO (μL mL^-1^)   MIC\* of CIP (μL mL^-1^)
  ---------------------- --------------------------------- ----------------------------- --------------------------
  *S.* Enteritidis 209   Ser 83-Tyr *gyrA* gene mutation   2.5                           0.12
                         Active AcrAB-TolC system          0                             0
  *S.* Typhimurium 149   Ser 83-Tyr *gyrA* gene mutation   2.5                           0.12
  *S.* Corvallis 297     PMRQ- *qnr*B1 plasmidial gene     5                             0.5

\*Resistance Mechanism previously characterized by

Souza et al. (2011)

and

Ferrari et al. (2013a

,

b

); \*\*MIC: Minimum Inhibitory Concentration; OVEO,

O. vulgare

L. essential oil; CIP, cirpofloxacin.

DETERMINATION OF MINIMUM INHIBITORY CONCENTRATION (MIC)
-------------------------------------------------------

A modified microtiter plate assay was used to determine the MIC of OVEO, NaCl, KCl, AA, LA, and CIP ([@B21]). The 96-well plates were prepared by dispensing 90 μL of OVEO (40--0.31 μL mL^-1^), salts (600--50 mg mL^-1^), acids (16--0.125 μL mL^-1^), or CIP solutions (0.005 μL mL^-1^ to 1 μL mL^-1^) into 90 μL of double-concentration BHI broth in each well. Finally, 10 μL of bacterial suspension (10^7^ CFU mL^-1^) were added to each well. The microplate was wrapped loosely with cling wrap to prevent bacterial dehydration and ensure that OVEO would not volatilize. Each plate included controls without the antimicrobial test agents. The plates were prepared in triplicate, and they were statically incubated at 37°C for 24 h in a microplate incubator/reader (EON model, Biotek Inc., USA). Following incubation, MIC values were confirmed as the lowest concentrations of OVEO, NaCl, KCl, AA, LA, or CIP at which the OD~660~ was less than 0.01 ([@B19]). Breakpoints that were designed by [@B5] were used to interpret MIC values of CIP \[[@B5]\]. All MIC determination assays were performed in triplicate and in three separate experiments. The results were expressed as modal values because no variation was observed between the replicated results ([@B18]).

EVALUATION OF INDUCTION OF BACTERIAL DIRECT-TOLERANCE AND BACTERIAL CROSS-TOLERANCE
-----------------------------------------------------------------------------------

The induction of direct-tolerance and cross-tolerance was performed by exposing the test strains to subinhibitory OVEO concentrations for different time intervals, followed by a determination of the MIC values for the homologous stressing agent (OVEO) or heterologous stressing agents (NaCl, KCl, AA, LA, and CIP; [@B16]). For this test, 4 mL of BHI broth was inoculated with 1 mL of bacterial suspension (c.a. 10^7^ CFU mL^-1^). Appropriate amounts of OVEO was added to obtain the desired final concentration ( MIC or MIC), followed by static incubation at 37°C. After 24, 48, and 72 h of incubation, an aliquot of each system was taken (standardized to OD~600~ values of 0.1, c.a. 10^7^ CFU mL^-1^ of habituated cells) as inoculum (10 μL) to determine the MIC of OVEO, or MIC of NaCl, KCl, AA, and LA using the same microtiter plate assay as described before ([@B21]). The induction of direct-tolerance and cross-tolerance in bacteria was tested by comparing the MIC values of OVEO or NaCl, KCl, AA, LA, and CIP against those of the tested strains before and after the habituation treatment with subinhibitory amounts of OVEO. Control systems without OVEO exposure were similarly tested (non-habituation treatment). All assays were performed in triplicate in three separate experiments, and the results were expressed as modal or median values. Only the modal values were presented in those experiments yielding same results ([@B18]). Significant differences (*P* \< 0.05) for induction of tolerance were considered when changes in MIC values were equal to or higher than a twofold increase (≥twofold increase; [@B12]).

RESULTS
=======

The MIC values of OVEO against the tested strains ranged from 2.5 μL mL^-1^ to 5 μL mL^-1^. Lower susceptibility to OVEO was observed in *S.* Corvallis 297 compared to *S.* Enteritidis 209 and *S.* Typhimurium 149 (**Table [1](#T1){ref-type="table"}**). MIC of CIP ranged from 0.12 μL mL^-1^ to 0.5 μL mL^-1^, which is considered to be a phenotype of reduced susceptibility to CIP according to the breakpoints designed by [@B5]. Similar to OVEO, the highest MIC of CIP was also observed against *S.* Corvallis 297. NaCl, KCl, AA, and LA yielded MIC values of 150 mg mL^-1^, 200 mg mL^-1^, 2.5 μL mL^-1^, and 10 μL mL^-1^, respectively, against all the assayed strains.

The habituation of the strains to OVEO during the assessed time-intervals (24, 48, and 72 h) caused a decrease in MIC values of all strains studied. Regardless of the tested *Salmonella* strain and the OVEO concentration used for habituation ( MIC or MIC; **Table [2](#T2){ref-type="table"}**), there was no induction of direct-tolerance in the bacterial cells for 72 h. The maximum decrease in MIC value of OVEO (fourfold double dilution) was observed in *S*. Corvallis (5 μL mL^-1^ to 0.3 μL mL^-1^; **Table [2](#T2){ref-type="table"}**). The decreased MIC values of OVEO against habituated *S. enterica* was related to the time of exposure to subinhibitory concentrations of OVEO because, with exception of *S.* Typhimurium 149 habituated to MIC of OVEO, the smallest MIC values were generally found against cells that were pre-exposed to OVEO for 72 h when compared with non-habituated. During all the assessed time intervals, the MIC values of OVEO against non-habituated cells ranged from 5 μL mL^-1^ to 2.5 μL mL^-1^.

###### 

The MIC of the essential oil from *O. vulgare* L. against multidrug-resistant *S. enterica* strains isolated from human outbreaks or from poultry origin, with or without habituation to the same stressing agent for 72 h.

  Strains                Treatment                        MIC (μL mL^-1^)          
  ---------------------- -------------------------------- ----------------- ------ -----
  *S.* Enteritidis 209   Control (0 μL OVEO mL^-1^)       2.5               2.5    2.5
                         MIC OVEO (1.25 μL OVEO mL^-1^)   2.5               1.25   0.3
                         MIC OVEO (0.6 μL OVEO mL^-1^)    2.5               1.25   0.3
  *S.* Typhimurium 149   Control (0 μL OVEO mL^-1^)       2.5               2.5    2.5
                         MIC OVEO (1.25 μL OVEO mL^-1^)   1.25              1.25   0.6
                         MIC OVEO (0.6 μL OVEO mL^-1^)    2.5               2.5    2.5
  *S.* Corvallis 297     Control (0 μL OVEO mL^-1^)       5                 5      5
                         MIC OVEO (2.5 μL OVEO mL^-1^)    2.5               1.25   0.3
                         MIC OVEO (1.25 μL OVEO mL^-1^)   2.5               2.5    2.5

\*Hours of previous habituation or not in the assayed sublethal concentrations of

O. vulgare

L. essential oil; MIC, minimum inhibitory concentration; OVEO,

O. vulgare

L. essential oil.

Similar to the direct-tolerance results, MIC values for NaCl, KCl, AA, and LA against the OVEO-habituated cells were the same or decreased (one to threefold double dilution), when compared with MIC values against non-habituated cells (**Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}**). There was no effect of time-of-habituation to OVEO on the sensitivity of the habituated cells to NaCl, KCl, and LA. However, the decrease in MIC values of AA against habituated-cells always occurred after 72 h of exposure to subinhibitory concentration of OVEO. MIC values of CIP against the habituated cells were maintained when compared with the previously determined MIC values, indicating that habituation to OVEO did not alter the sensitivity of the strains to CIP. A transient decrease (two-fold double dilution) of MIC values of CIP against *S.* Enteritidis 209 was observed after 48 h of habituation to MIC and MIC of OVEO.

###### 

Minimum inhibitory concentrations of sodium chloride, potassium chloride, acetic acid, and lactic acid against multidrug-resistant *S. enterica* strains isolated from human outbreaks or from poultry origin, with or without habituation to the essential oil from *O. vulgare* L. for 72 h.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strains                Treatment                        Sodium chloride (NaCl)\   Potassium chloride (KCL)\   Acetic acid\      Lactic acid\      Ciprofloxacin (CIP)\                                                           
                                                          MIC (mg mL^-1^)           MIC (mg mL^-1^)             MIC (μL mL^-1^)   MIC (μL mL^-1^)   MIC (μL mL^-1^)                                                                
  ---------------------- -------------------------------- ------------------------- --------------------------- ----------------- ----------------- ---------------------- ----- ----- ----- ------ ---- ---- ------ ------ ------ ------
  *S.* Enteritidis 209   Control (0 μL OVEO mL^-1^)       150                       150                         150               200               200                    200   2.5   2.5   2.5    10   10   10     0.12   0.12   0.12

                         MIC OVEO (1.25 μL OVEO mL^-1^)   150                       75                          75                200               100                    75    2.5   2.5   1.25   5    5    1.25   0.12   0.5    0.12

                         MIC OVEO (0.6 μL OVEO mL^-1^)    150                       75                          75                200               200                    75    2.5   2.5   1.25   5    5    1.25   0.12   0.5    0.12

                                                                                                                                                                                                                                   

  *S.* Typhimurium 149   Control (0 μL OVEO mL^-1^)       150                       150                         100               200               200                    200   2.5   2.5   2.5    10   5    5      0.12   0.12   0.12

                         MIC OVEO (1.25 μL OVEO mL^-1^)   150                       100                         75                100               75                     50    2.5   2.5   2.5    5    5    5      0.12   0.12   0.12

                         MIC OVEO (0.6 μL OVEO mL^-1^)    150                       150                         150               200               200                    100   2.5   2.5   2.5    5    5    5      0.12   0.12   0.12

                                                                                                                                                                                                                                   

  *S.* Corvallis 297     Control (0 μL OVEO mL^-1^)       150                       150                         100               200               200                    200   2.5   2.5   2.5    10   5    5      0.5    0.5    0.5

                         MIC OVEO (2.5 μL OVEO mL^-1^)    50                        50                          50                200               200                    50    2.5   2.5   1.25   5    5    1.25   0.5    0.5    0.5

                         MIC OVEO (1.25 μL OVEO mL^-1^)   50                        50                          50                200               200                    50    2.5   2.5   1.25   5    5    1.25   0.5    0.5    0.5
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Hours of previous habituation (or not) to

O. vulgare

L. essential oil at the assayed sublethal concentrations; MIC, minimum inhibitory concentration; OVEO,

O. vulgare

L. essential oil.

DISCUSSION
==========

*Salmonella enterica* presents a dynamic interaction with host and environment and has a high genetic variability related to the development of different antimicrobial resistance mechanisms ([@B8]; [@B6]). The serovars *S.* Enteritidis and *S.* Typhimurium are frequently cited as more tolerant to many antimicrobials agents when compared to other *Salmonella* serovars ([@B24]; [@B9]; [@B4]). However, in the present study MIC values of OVEO and CIP were higher against *S.* Corvallis 297 when compared to the values against *S.* Enteritidis 209 and *S.* Typhimurium 149. The presence of *qnr*B19 gene in *S.* Corvalis 297 ([@B8]), a well-known mechanism of resistance to quinolone in *Salmonella*, could be related to the higher tolerance of the strains to the substances that were tested.

*Salmonella* Corvallis 297 showed the most decrease (fourfold double dilution) in MIC values of OVEO after habituation for 72 h and was the only strain that exhibited a significant decrease \[more than onefold double dilution; [@B5]\] in MIC of NaCl and this decrease occurred at the 24 h time point (**Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}**). The behavior of *S.* Corvallis could be associated with the low expression of AcrAB-TolC eﬄux pump related genes that has been previously described in this strain ([@B9]). AcrAB-TolC is a well-known eﬄux system in *S. enterica* which is able to help in extrusion of bile salts, lipophilic antibiotics, dyes, detergents, and solvents from the cell. The expression of genes related to this eﬄux system has been associated with multiple-drug resistance ([@B25]), which is observed among the *Salmonella* strains assayed in this study. However, this explanation is in contrast with the behavior of *S.* Enteritidis 209, in which, despite high expression levels of AcrAB-TolC eﬄux pump related genes, the sensitivity to OVEO was increased (threefold double dilution decrease in MIC value) but the sensitivity to NaCl remained unaltered after habituation ([@B9]). Changes in the cell wall structure and increased membrane permeability have been observed in Gram-negative bacteria that were exposed to sublethal concentrations of OVEO ([@B23]). These alterations in membrane structure, caused by the exposure to OVEO, could have affected the osmoregulation ability of the membrane or its capacity to extrude toxic materials and, therefore, increased the sensitivity of the tested *Salmonella* strains to OVEO, salts and acids. Changes in the cellular membrane fatty acids composition of *S.* Typhimurium that were subjected to habituation to OVEO at subinhibitory concentrations have been reported earlier ([@B17]). Even if an adaptation-response related changes in membrane occurred in the tested strains, these changes were not capable of causing obvious increase (≥twofold doubling dilution; [@B12]) in MIC values of OVEO, salts and acids, and therefore, conferring the development of direct-tolerance or cross-tolerance. In this study, non-induction of cross-tolerance to salts and acids after habituation to OVEO is noteworthy because the development of homologous and heterologous tolerance in *S. enterica* that were challenged with subinhibitory conditions, provided by other antimicrobial compounds or procedures used for controlling microbial growth and survival in foods, has already been documented ([@B7]). Previous studies have found development of cross-tolerance in *S. enterica* after habituation to LA ([@B15]), AA ([@B1], [@B3]), NaCl, and KCl ([@B11]).

Maintenance of susceptibility to CIP after exposure to OVEO for an extended period was noticeable in the tested *Salmonella* strains. The multidrug-resistant phenotypes of these strains, with resistance to a variety of antibiotic classes that target different cellular components including the cell membrane, make this observation distinctive. Changes in antibiotic susceptibility in *S.* Typhimurium ST11 and *S.* Enteritidis NCTC 12694 after habituation to subinhibitory concentrations of *Melaleuca alternifolia* L. essential oil have been reported earlier. These changes in antibiotic susceptibility were associated with increase (≥twofold double dilution) in MIC values of gentamicin, erythromycin, chloramphenicol, tetracycline, streptomycin, and trimethoprim ([@B19]).

To our knowledge, this is the first study that investigated the tolerance development by multidrug-resistant *S. enterica* strains after habituation to subinhibitory concentrations of OVEO. These results revealed that habituating *S. enterica* strains to subinhibitory amounts of OVEO maintained or increased susceptibility to the same stressing agent and also to the tested heterologous stressing agents (NaCl, KCl, LA, AA, and CIP).
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